Los Angeles, CA22 Active Studies

Multiple Sclerosis Clinical Trials in Los Angeles, CA

Find 22 actively recruiting multiple sclerosis clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

22
Active Trials
16
Sponsors
10,066
Enrolling

Recruiting Multiple Sclerosis Studies in Los Angeles

About Multiple Sclerosis Clinical Trials in Los Angeles

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 22 multiple sclerosis clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 10,066 participants. Research is being sponsored by Children's Oncology Group, Eli Lilly and Company, University of Michigan Rogel Cancer Center and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Los Angeles — FAQ

Are there multiple sclerosis clinical trials in Los Angeles?

Yes, there are 22 multiple sclerosis clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 22 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 17, 2026 from ClinicalTrials.gov